Actively Recruiting
Led by Janssen Pharmaceutica N.V., Belgium · Updated on 2026-06-05
300
Participants Needed
89
Research Sites
13 weeks
Total Duration
Researchers are evaluating the effectiveness, safety, and patient-reported outcomes of standard antimyeloma treatments in people with relapsed and/or refractory multiple myeloma over a 24-month period. This observational study focuses on participants who have previously received treatment and aims to understand real-life clinical practice outcomes. The study is sponsored by Janssen Pharmaceutica N.V., Belgium, and collects data from routine medical care without interventional treatments. Participants with relapsed/refractory multiple myeloma receiving standard antimyeloma treatments as part of their regular clinical care will be observed. The primary source of data will be the participants' medical records. There is no experimental drug or placebo involved. The study includes different observation periods to assess various outcomes related to response rates, disease progression, and quality of life. During the study, researchers will review participants' medical records and track a wide range of outcomes including overall response rate, progression-free survival, adverse events, and health-related quality of life using validated questionnaires. The study follows participants for up to 52 months, monitoring treatment responses, safety, and patient-reported oral toxicities. This long-term observation helps to understand treatment effectiveness and patient experiences in everyday clinical settings.
CONDITIONS
A Study of Real-Life Current Standards of Care in Participants With Relapsed and/or Refractory Multiple Myeloma
You may qualify if you...
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 52 months
Participants with relapsed/refractory multiple myeloma receiving antimyeloma treatment as standard of care under routine clinical practice are observed.
Visits as per routine clinical practice for up to 52 months
Total: 89 locations
1
LKH Leoben
Leoben, Austria, 8700
Actively Recruiting
2
Krankenhaus der barmherzigen Schwestern
Vienna, Austria, 1060
Actively Recruiting
3
UZ Antwerpen
Edegem, Belgium, 2650
Actively Recruiting
4
Ziekenhuis Oost-Limburg
Genk, Belgium, 3600
Actively Recruiting
5
UZ Leuven
Leuven, Belgium, 3000
Completed
6
Chu Helora Hospital De Mons Site Kennedy
Mons, Belgium, 7000
Actively Recruiting
7
Vitaz
Sint-Niklaas, Belgium, 9100
Actively Recruiting
8
Ucl de Mont-Godinne
Yvoir, Belgium, 5530
Completed
9
CHRU de Lille Hopital Claude Huriez
Lille, France, 59037
Completed
10
CHU de Montpellier Hopital Saint Eloi
Montpellier, France, 34295
Completed
11
CHU de Nantes hotel Dieu
Nantes, France, 44093
Completed
12
Centre hospitalier Lyon-Sud
Pierre-Bénite, France, 69495
Completed
13
Pôle IUC Oncopole CHU
Toulouse, France, 31059
Completed
14
Charite Universitaetsmedizin Berlin - Campus Benjamin Franklin
Berin, Germany, 12203
Completed
15
Universitaetsklinikum Koeln
Cologne, Germany, 50397
Completed
16
Universitatsklinikum Carl Gustvav Carus Dresden an der Technischen Universitat Dresden
Dresden, Germany, 01307
Completed
17
Universitätsklinik Hamburg-Eppendorf - Orthopädische Universitätsklinik und Poliklinik
Hamburg, Germany, 20251
Completed
18
St. Barbara-Klinik Hamm GmbH
Hamm, Germany, 59073
Completed
19
Universitaetsklinikum Heidelberg
Heidelberg, Germany, 69120
Completed
20
Staedtisches Klinikum Karlsruhe gGmbH
Karlsruhe, Germany
Completed
21
MVZ Mitte-Onkologische Schwerpunktpraxis
Leipzig, Germany, 04103
Completed
22
Universitaetsklinikum Leipzig
Leipzig, Germany, 4103
Completed
23
Klinikum der Eberhard Karls Universitaet Abt fur innere Med II Haematologie Onkologie Germany
Tübingen, Germany, 72076
Completed
24
Universitatsklinikum Wurzburg
Würzburg, Germany, 97080
Completed
25
Heinrich-Braun-Klinikum gGmbH
Zwickau, Germany, 08060
Completed
26
University Hospital of Alexandroupolis
Alexandroupoli, Greece, 68100
Actively Recruiting
27
Henry Dunant Hospital Center
Athens, Greece, 115 26
Actively Recruiting
28
Laiko General Hospital Of Athens 1
Athens, Greece, 115 27
Actively Recruiting
29
Laiko General Hospital of Athens 2
Athens, Greece, 115 27
Actively Recruiting
30
Alexandra Hospital
Athens, Greece, 115 28
Actively Recruiting
31
Metaxa Cancer Center Hospital Of Piraeus
Piraeus, Greece, 18537
Actively Recruiting
32
General University Hospital of Patras
Rio, Greece, 265 04
Actively Recruiting
33
Anticancer Hospital of Thessaloniki Theageneio
Thessaloniki, Greece, 546 39
Actively Recruiting
34
Ahepa University General Hospital of Thessaloniki
Thessaloniki, Greece, 54636
Actively Recruiting
35
Oncologia Medica - Irccs - Istituto Tumori Giovanni Paolo II
Bari, Italy, 70124
Completed
36
U.O. Ematologia Istituto Tumori Giovanni Paolo II
Bari, Italy, 70124
Actively Recruiting
37
Istituto di Ematologia Seràgnoli azienda ospedaliera univeristaria Policlinico S.Orsola-Malpighi
Bologna, Italy, 40138
Actively Recruiting
38
Policlinico di Catania
Catania, Italy, 95128
Completed
39
Ospedale Civile di Civitanova Marche
Civitanova Marche, Italy, 62012
Actively Recruiting
40
IRCCS Azienda Ospedaliera San Martino - IST
Genova, Italy, 16132
Completed
41
Ospedale Policlinico San Martino IRCCS
Genova, Italy, 16132
Actively Recruiting
42
Ospedale Vito Fazzi
Lecce, Italy, 73100
Actively Recruiting
43
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori
Meldola, Italy, 47014
Completed
44
Universita degli Studi di Padova Azienda Ospedaliera di Pa
Padova, Italy, 35128
Completed
45
Ospedale Villa Sofia-Cervello
Palermo, Italy, 90146
Actively Recruiting
46
Fondazione IRCCS Policlinico San Matteo
Pavia, Italy, 27100
Actively Recruiting
47
Presidio Ospedaliero Pescara
Pescara, Italy, 65124
Actively Recruiting
48
Grande Ospedale Metropolitano 'Bianchi-Melacrino-Morelli' Reggio Calabria
Reggio Calabria, Italy, 89124
Actively Recruiting
49
Università di Roma La Sapienza
Roma, Italy, 00161
Completed
50
Fondazione Policlinico Universitario A Gemelli IRCCS
Roma, Italy, 00168
Actively Recruiting
51
Campus Bio Medico di Roma
Roma, Italy, 128
Actively Recruiting
52
Casa Sollievo Della Sofferenza IRCCS
San Giovanni Rotondo, Italy, 71013
Actively Recruiting
53
IRCCS Ospedale Casa Sollievo della Sofferenza
San Giovanni Rotondo, Italy, 71013
Completed
54
Ospedale Cardinale G. Panico
Tricase, Italy, 73039
Completed
55
Azienda Ulss 8 Berica- Ospedale Di Vicenza
Vicenza, Italy, 36100
Actively Recruiting
56
VU Medisch Centrum
Amsterdam, Netherlands, 1081 HV
Completed
57
UMCG
Groningen, Netherlands, 9713 GZ
Completed
58
Ulstmad - Hosp. Chaves
Chaves, Portugal, 5400 482
Actively Recruiting
59
Uls Coimbra - Hosp. Univ. Coimbra
Coimbra, Portugal, 3004 561
Actively Recruiting
60
Uls Sao Joao - Hosp. Sao Joao
Porto, Portugal, 4200 319
Actively Recruiting
61
Fundeni Clinical Institute
Bucharest, Romania, 022328
Actively Recruiting
62
Institutul Oncologic Prof Dr. Ion Chiricuta Cluj Napoca 1
Cluj-Napoca, Romania, 400015
Actively Recruiting
63
Inst. Cat. Doncologia-H Duran I Reynals
Barcelona, Spain, 08908
Completed
64
Hosp. de Cabuenes
Gijón, Spain, 33394
Actively Recruiting
65
Hosp. Univ. Virgen de Las Nieves
Granada, Spain, 18014
Actively Recruiting
66
Hosp. de Jerez de La Frontera
Jerez de la Frontera, Spain, 11407
Completed
67
Hosp. de Leon
León, Spain, 24008
Actively Recruiting
68
Hosp. Univ. Ramon Y Cajal
Madrid, Spain, 28034
Completed
69
Hosp. Univ. 12 de Octubre
Madrid, Spain, 28041
Completed
70
Hosp. Univ. Son Espases
Palma, Spain, 7120
Actively Recruiting
71
Clinica Univ. de Navarra
Pamplona, Spain, 31008
Completed
72
Hosp Clinico Univ de Salamanca
Salamanca, Spain, 37007
Actively Recruiting
73
Hosp. Univ. Marques de Valdecilla
Santander, Spain, 39008
Actively Recruiting
74
Hosp. Clinico Univ. de Santiago
Santiago de Compostela, Spain, 15706
Completed
75
Hosp. Clinico Univ. de Valencia
Valencia, Spain, 46010
Actively Recruiting
76
Hosp. Univ. Dr. Peset
Valencia, Spain, 46017
Actively Recruiting
77
Hosp. Clinico Univ. de Valladolid
Valladolid, Spain, 47003
Completed
78
Hosp. Univ. Miguel Servet
Zaragoza, Spain, 50009
Actively Recruiting
79
Kantonsspital Graubunden
Chur, Switzerland, 7000
Actively Recruiting
80
Kantonsspital Winterthur, Medizinische Onkologie
Winterthur, Switzerland, 8400
Actively Recruiting
81
Hirslanden Klinik Hirslanden
Zurich, Switzerland, 8032
Actively Recruiting
82
Universitatsspital Zurich
Zurich, Switzerland, 8091
Actively Recruiting
83
Southmead Hospital
Bristol, United Kingdom, BS10 5NB
Completed
84
University College Hospital
London, United Kingdom, NW1 2PG
Completed
85
Kings College Hospital
London, United Kingdom, SE5 9RS
Completed
86
St Georges Hospital
London, United Kingdom, SW17 OQT
Completed
87
Maidstone Hospital
Maidstone, United Kingdom, ME16 9QQ
Completed
88
Nottingham University Hospitals NHS Trust
Nottingham, United Kingdom, NG5 1PB
Completed
89
The Royal Marsden NHS Trust Sutton
Surrey, United Kingdom, SM2 5PT
Completed
S
Study Contact
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Hermann Einsele, Philippe Moreau, Nizar Bahlis...
https://pubmed.ncbi.nlm.nih.gov/41313549Hermann Einsele, Philippe Moreau, Nizar Bahlis...
https://pubmed.ncbi.nlm.nih.gov/38402374Philippe Moreau, María-Victoria Mateos, Maria Esther Gonzalez Garcia...
https://pubmed.ncbi.nlm.nih.gov/38110653